Ajay Yekkirala PhD

Ajay Yekkirala, PhD, is Co-Founder and SVP, Head of Discovery and Development at Superluminal Medicines Inc., focusing on target receptor-receptor interactions for various clinical indications, including pain, irritable bowel syndrome, Parkinson’s disease, anxiety, and breast cancer applications. Previously, he served as VP Head of Biology at RA Capital Management and Co-Founder & CSO at Blue Therapeutics, where he developed biotechnology platforms and managed investment portfolios in the life sciences sector. He completed his PhD in Pharmacology, Neuroscience, and Medicinal Chemistry at the University of Minnesota Medical School and holds postdoctoral training in Neuroscience from Harvard Medical School. Dr. Yekkirala has extensive experience in drug discovery and development, with expertise in neuroimmunology, pain, and nerve regeneration research and receptor biology applications.